Roche returns to China’s Hansoh for $15B biobucks ADC pact - Fierce Biotech
Source: Fierce Biotech ·
Roche returns to China’s Hansoh for $15B biobucks ADC pact Fierce BiotechChina's Hansoh Pharma strikes drug deal with Roche worth over $15 billion ReutersRoche Partners With China’s Hansoh in Deal That Could Top $15 Billion WSJRoche, Hansoh expand ADC alliance in deal with $15B-plus potential FirstWord PharmaRoche does $400M upfront, $15B deal with China’s Hansoh Endpoints News
BestAIBroker analysis
- Finance-aware sentiment: positive (+0.70 on a -1 to +1 scale).
- Event classification: OTHER.
- Market importance score: 23/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
- Symbols referenced: ADC.